Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Christoph Wanner

Showing results (431-440 of 666) with videos related to

Pageof 67
Sort By:
American Journal of Kidney Diseases : the Official Journal of the National Kidney Foundation|March 15, 2022
Heart-Type Fatty Acid Binding Protein, Cardiovascular Outcomes, and Death: Findings From the German CKD Cohort StudyMarkus P Schneider, Matthias Schmid, Jennifer Nadal, et al.
Journal of Internal Medicine|December 16, 2021
Apolipoprotein A-IV concentrations and clinical outcomes in a large chronic kidney disease cohort: Results from the GCKD studyJohannes P Schwaiger, Barbara Kollerits, Inga Steinbrenner, et al.
Kidney International|July 10, 2020
Results from the German Chronic Kidney Disease (GCKD) study support association of relative telomere length with mortality in a large cohort of patients with moderate chronic kidney diseaseFederica Fazzini, Claudia Lamina, Julia Raschenberger, et al.
Cardiovascular Diabetology|June 20, 2014
Rationale, design, and baseline characteristics of a randomized, placebo-controlled cardiovascular outcome trial of empagliflozin (EMPA-REG OUTCOME™)Bernard Zinman, Silvio E Inzucchi, John M Lachin, et al.
Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association|January 17, 2020
Kidney function and symptom development over time in elderly patients with advanced chronic kidney disease: results of the EQUAL cohort studyCynthia J Janmaat, Merel van Diepen, Yvette Meuleman, et al.
Science Translational Medicine|March 8, 2013
Carbamylation of serum albumin as a risk factor for mortality in patients with kidney failureAnders H Berg, Christiane Drechsler, Julia Wenger, et al.
American Journal of Kidney Diseases : the Official Journal of the National Kidney Foundation|May 16, 2015
Characteristics and Outcomes of Granulomatosis With Polyangiitis (Wegener) and Microscopic Polyangiitis Requiring Renal Replacement Therapy: Results From the European Renal Association-European Dialysis and Transplant Association RegistryZdenka Hruskova, Vianda S Stel, David Jayne, et al.
Journal of the American Society of Nephrology : JASN|March 9, 2021
Kidney Failure Prediction Models: A Comprehensive External Validation Study in Patients with Advanced CKDChava L Ramspek, Marie Evans, Christoph Wanner, et al.
Nature Reviews. Nephrology|August 23, 2023
Diagnosis of cardiovascular disease in patients with chronic kidney diseaseCarmine Zoccali, Patrick B Mark, Pantelis Sarafidis, et al.
Kidney International|July 16, 2017
Challenges in conducting clinical trials in nephrology: conclusions from a Kidney Disease-Improving Global Outcomes (KDIGO) Controversies ConferenceColin Baigent, William G Herrington, Josef Coresh, et al.
Pageof 67

Showing results (431-440 of 666) with videos related to

Sort By:
Pageof 67
American Journal of Kidney Diseases : the Official Journal of the National Kidney Foundation|March 15, 2022
Heart-Type Fatty Acid Binding Protein, Cardiovascular Outcomes, and Death: Findings From the German CKD Cohort StudyMarkus P Schneider, Matthias Schmid, Jennifer Nadal, et al.
Journal of Internal Medicine|December 16, 2021
Apolipoprotein A-IV concentrations and clinical outcomes in a large chronic kidney disease cohort: Results from the GCKD studyJohannes P Schwaiger, Barbara Kollerits, Inga Steinbrenner, et al.
Kidney International|July 10, 2020
Results from the German Chronic Kidney Disease (GCKD) study support association of relative telomere length with mortality in a large cohort of patients with moderate chronic kidney diseaseFederica Fazzini, Claudia Lamina, Julia Raschenberger, et al.
Cardiovascular Diabetology|June 20, 2014
Rationale, design, and baseline characteristics of a randomized, placebo-controlled cardiovascular outcome trial of empagliflozin (EMPA-REG OUTCOME™)Bernard Zinman, Silvio E Inzucchi, John M Lachin, et al.
Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association|January 17, 2020
Kidney function and symptom development over time in elderly patients with advanced chronic kidney disease: results of the EQUAL cohort studyCynthia J Janmaat, Merel van Diepen, Yvette Meuleman, et al.
Science Translational Medicine|March 8, 2013
Carbamylation of serum albumin as a risk factor for mortality in patients with kidney failureAnders H Berg, Christiane Drechsler, Julia Wenger, et al.
American Journal of Kidney Diseases : the Official Journal of the National Kidney Foundation|May 16, 2015
Characteristics and Outcomes of Granulomatosis With Polyangiitis (Wegener) and Microscopic Polyangiitis Requiring Renal Replacement Therapy: Results From the European Renal Association-European Dialysis and Transplant Association RegistryZdenka Hruskova, Vianda S Stel, David Jayne, et al.
Journal of the American Society of Nephrology : JASN|March 9, 2021
Kidney Failure Prediction Models: A Comprehensive External Validation Study in Patients with Advanced CKDChava L Ramspek, Marie Evans, Christoph Wanner, et al.
Nature Reviews. Nephrology|August 23, 2023
Diagnosis of cardiovascular disease in patients with chronic kidney diseaseCarmine Zoccali, Patrick B Mark, Pantelis Sarafidis, et al.
Kidney International|July 16, 2017
Challenges in conducting clinical trials in nephrology: conclusions from a Kidney Disease-Improving Global Outcomes (KDIGO) Controversies ConferenceColin Baigent, William G Herrington, Josef Coresh, et al.
Pageof 67